Large-Cap Stocks: GE HealthCare to Sell, Carvana and McKesson to Watch
ByAinvest
Monday, Jul 14, 2025 4:21 am ET1min read
CVNA--
GEHC's stock has observed a 1.8% dip over the past 52 weeks, underperforming the Health Care Select Sector SPDR Fund (XLV), which has declined by 6.5%, and the S&P 500 Index ($SPX), which has seen a 12.3% drop [1]. The company reported a strong start to the year, with its stock prices gaining 3.3% after the release of its Q1 results on April 30. Organic revenues grew by 2.7% year-over-year to $4.8 billion, driven by strengthening sales in the U.S. [1].
For the full fiscal 2025, analysts expect GEHC to deliver an EPS of $4.02, down 10.5% from $4.49 reported in the previous year. In fiscal 2026, its earnings are expected to rebound by 12.2% year-over-year to $4.51 per share [1]. Despite these projections, the company's stock holds a consensus "Strong Buy" rating, with 13 analysts rating it as a "Strong Buy," one as a "Moderate Buy," and five as a "Hold." The mean price target of $87.16 suggests a 15.4% upside potential from current price levels [1].
In contrast, Carvana (CVNA) and McKesson (MCK) are large-cap stocks to watch. Carvana has seen growing retail units sold and highly profitable incremental sales, making it an attractive stock for investors. McKesson, with a long history and a diversified healthcare services business, also presents opportunities for growth [2].
References:
[1] https://finance.yahoo.com/news/know-ahead-ge-healthcare-technologies-071630284.html
[2] https://www.tradingview.com/news/gurufocus:65c90b6f2094b:0-healthcare-services-group-slides-on-genesis-bankruptcy/
GE--
GEHC--
MCK--
GE HealthCare (GEHC) is a large-cap stock to sell due to sluggish demand and flat earnings per share. Carvana (CVNA) is a large-cap stock to watch with growing retail units sold and highly profitable incremental sales. McKesson (MCK) is another large-cap stock to watch, with a long history and a diversified healthcare services business.
GE HealthCare Technologies Inc. (GEHC), a leading designer of medical imaging and patient-monitoring products, is facing challenges that may warrant a sell signal for investors. The company, valued at $34.4 billion by market cap, is set to release its second-quarter results on July 30. Analysts expect a profit of $0.91 per share, down 9% from the $1 per share reported in the year-ago quarter. Despite this expected decline, GEHC has a history of surpassing earnings estimates, having done so in each of the past four quarters [1].GEHC's stock has observed a 1.8% dip over the past 52 weeks, underperforming the Health Care Select Sector SPDR Fund (XLV), which has declined by 6.5%, and the S&P 500 Index ($SPX), which has seen a 12.3% drop [1]. The company reported a strong start to the year, with its stock prices gaining 3.3% after the release of its Q1 results on April 30. Organic revenues grew by 2.7% year-over-year to $4.8 billion, driven by strengthening sales in the U.S. [1].
For the full fiscal 2025, analysts expect GEHC to deliver an EPS of $4.02, down 10.5% from $4.49 reported in the previous year. In fiscal 2026, its earnings are expected to rebound by 12.2% year-over-year to $4.51 per share [1]. Despite these projections, the company's stock holds a consensus "Strong Buy" rating, with 13 analysts rating it as a "Strong Buy," one as a "Moderate Buy," and five as a "Hold." The mean price target of $87.16 suggests a 15.4% upside potential from current price levels [1].
In contrast, Carvana (CVNA) and McKesson (MCK) are large-cap stocks to watch. Carvana has seen growing retail units sold and highly profitable incremental sales, making it an attractive stock for investors. McKesson, with a long history and a diversified healthcare services business, also presents opportunities for growth [2].
References:
[1] https://finance.yahoo.com/news/know-ahead-ge-healthcare-technologies-071630284.html
[2] https://www.tradingview.com/news/gurufocus:65c90b6f2094b:0-healthcare-services-group-slides-on-genesis-bankruptcy/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet